PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
27-May-2025 BC Platforms Appoints Senior Product and Marketing Executives to Further Advance Global Expansion and Real-World Data Leadership BC Platforms
21-May-2025 PSI Named a 2025 Fierce CRO Award Finalist for Excellence in Clinical Trial Management PSI CRO
20-May-2025 Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting Santhera
20-May-2025 Eleva Appoints Donato Spota as Chief Financial Officer Eleva
20-May-2025 Brainomix Presents Robust Validation of Its FDA-Cleared e-Lung Technology from its Collaboration with Boehringer Ingelheim Brainomix
20-May-2025 Another Day Pharma announces promising Phase II results for topical post-prostatectomy erectile dysfunction treatment Another Day Pharma Ltd
20-May-2025 Journal of Critical Care publishes positive results from prespecified, biomarker-guided subgroup analysis of AdrenoMed’s Phase II AdrenOSS-2 trial in septic shock AdrenoMed AG
14-May-2025 Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited Medeze
14-May-2025 Kaerus Bioscience’s lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS) Kaerus Bioscience
14-May-2025 Recipharm and PLG announce strategic partnership to accelerate development projects ProductLife Group
13-May-2025 SMC approval of BALVERSA®▼ (erdafitinib) helps pave the way for first licensed bladder cancer therapy that specifically targets fibroblast growth factor receptor (FGFR3) alterations Johnson & Johnson
12-May-2025 Pivotal supports expansion of enGene Clinical Trial for bladder cancer treatment into Europe PIVOTAL
09-May-2025 Vesper Bio achieves enrolment milestone in Phase Ib/IIa trial of lead candidate VES001 for frontotemporal dementia Vesper Bio
09-May-2025 iOnctura commences randomized Phase I/II study in non-small cell lung cancer iOnctura
07-May-2025 Enhertu followed by THP before surgery showed statistically significant and clinically meaningful improvement in pathologic complete response in patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial Astrazeneca
07-May-2025 ELRIG Announces Keynote Speakers for Drug Discovery 2025 ELRIG
01-May-2025 First patient enrolled in Phase 1 clinical trial of Akiram’s cancer drug candidate AKIR001 Akiram Therapeutics
01-May-2025 PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference PureTech
01-May-2025 argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) argenx
30-Apr-2025 Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025 Domain Therapeutics